论文部分内容阅读
中国是食管癌的高发国家,外科手术是我国食管癌的主要治疗手段,但单纯手术对于中晚期食管癌的治疗效果不尽如人意.为了提高食管癌的疗效,国内外学者进行了多种综合治疗模式的探索,包括术前放疗、术前化疗、术后放疗等,其中术前新辅助治疗的治疗模式特别引人关注,术前新辅助治疗,包括术前放化疗和术前化疗,尤其是前者有望提高食管癌患者的预后.术后化疗、术后放疗在我国也有应用的经验,本文拟对以手术为主的食管癌综合治疗的循证医学证据作一综述.
China is a high incidence of esophageal cancer, surgery is the main treatment of esophageal cancer in our country, but simple surgery for the treatment of advanced esophageal cancer is not satisfactory .In order to improve the efficacy of esophageal cancer, domestic and foreign scholars conducted a variety of comprehensive The mode of treatment, including preoperative radiotherapy, preoperative chemotherapy, postoperative radiotherapy, etc. Among them, the mode of treatment of preoperative neoadjuvant therapy is of particular concern, preoperative neoadjuvant therapy, including preoperative radiotherapy and chemotherapy and preoperative chemotherapy, especially Is the former is expected to improve the prognosis of patients with esophageal cancer.Postoperative chemotherapy, postoperative radiotherapy in our country also has applied experience, this article intends to surgery based esophageal cancer comprehensive treatment of evidence-based medicine is reviewed.